Murat Isbilen
Overview
Explore the profile of Murat Isbilen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Padzinska-Pruszynska I, Akbar M, Isbilen M, Gorka E, Kucukkaraduman B, Demirkol Canli S, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892243
This research paper presents a novel approach to identifying biomarkers that can be used to prognosticate patients with triple-negative breast cancer (TNBC) eligible for neoadjuvant therapy. The study utilized survival...
2.
Hill R, Madureira P, Ferreira B, Baptista I, Machado S, Colao L, et al.
Nat Commun
. 2023 Jul;
14(1):4341.
PMID: 37468494
No abstract available.
3.
In Silico Evaluation of SARS-CoV-2 K417N, L452R, and E484K Detection Assays Against Omicron Variants
Sayan M, Arikan A, Isbilen M
New Microbiol
. 2023 May;
46(2):133-140.
PMID: 37247233
The study's objective was to assess whether the performance of the DIAGNOVITAL SARS-CoV-2 Mutation Detection Assays is affected by Omicron mutations. In silico evaluation of 67,717 Variant of Concern, Variant...
4.
Akgun H, Metintas S, Ak G, Demirkol Canli S, Isbilen M, Gure A, et al.
Arch Med Sci
. 2023 Apr;
19(2):355-364.
PMID: 37034513
Introduction: The prognosis of malignant pleural mesothelioma (MPM) is poor, with a limited survival time. In this study, we aimed to examine expression levels of genes selected from relevant literature...
5.
Inal Gultekin G, Timirci Kahraman O, Isbilen M, Durmus S, Cakir T, Yaylim I, et al.
J Egypt Natl Canc Inst
. 2022 Dec;
34(1):54.
PMID: 36529823
Background: The bladder cancer (BC) pathology is caused by both exogenous environmental and endogenous molecular factors. Several genes have been implicated, but the molecular pathogenesis of BC and its subtypes...
6.
Sayan M, Arikan A, Isbilen M
Can J Infect Dis Med Microbiol
. 2022 Oct;
2022:4677720.
PMID: 36284529
The diagnosis of new variants and monitoring their potential effects on diagnosis, therapeutics, and vaccines by genomic sequencing is essential to manage global public crises. In the current study, spike-genome...
7.
Bayirli-Turan D, Usanmaz M, Gorgun S, Yolcu E, Sahin C, Bilenoglu O, et al.
Clin Lab
. 2022 Oct;
68(10).
PMID: 36250839
Background: The rapid spread of the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) which causes the coronavirus disease 2019 (COVID-19) facilitated the emergence of numerous variants. The present study aimed...
8.
Sayan M, Arikan A, Isbilen M
J Comp Eff Res
. 2022 Jan;
11(3):157-167.
PMID: 35014556
This study determined SARS-CoV-2 variations by phylogenetic and virtual phenotyping analyses. Strains isolated from 143 COVID-19 cases in Turkey in April 2021 were assessed. Illumina NexteraXT library preparation kits were...
9.
Turk S, Turk C, Akbar M, Kucukkaraduman B, Isbilen M, Demirkol Canli S, et al.
PLoS One
. 2020 Nov;
15(11):e0242497.
PMID: 33237942
Despite the availability of various treatment protocols, response to therapy in patients with Acute Myeloid Leukemia (AML) remains largely unpredictable. Transcriptomic profiling studies have thus far revealed the presence of...
10.
Kucukkaraduman B, Turk C, Fallacara A, Isbilen M, Senses K, Ayyildiz Z, et al.
ACS Med Chem Lett
. 2020 May;
11(5):928-932.
PMID: 32435407
Melanoma is a highly aggressive cancer with poor prognosis. Although more than 80% of melanomas harbor an activating mutation in genes within the MAPK pathway, which are mutually exclusive, usefulness...